Basel, Switzerland – Genedata, a leading provider of advanced software solutions for drug discovery and life science research, announced that Genedata has broadened its relationship with MorphoSys. Under the expanded collaboration, Genedata has successfully implemented new Genedata Biologics™ capabilities to further streamline MorphoSys’ antibody discovery and optimization workflows and to broaden integration with MorphoSys’ latest […]
Venlo, The Netherlands, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced its decision to change the offer conditions for the acquisition of shares in Exiqon A/S, reducing the threshold from 90% to 89.20%. All other terms and conditions remain unchanged. In line with the Danish Takeover Order, which requires the extension of an […]
STRATEC Biomedical AG, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard, TecDAX), signed an agreement with Sony DADC Austria AG (”Sony DADC”), based in Anif/Salzburg, Austria, to acquire all of the shares of its BioSciences business, Sony DADC BioSciences GmbH (”Sony DADC BioSciences”), which is a wholly-owned subsidiary of Sony DADC. The acquisition is expected to be […]
Copenhagen, – QIAGEN N.V., Company reg. no. 804803778 (“QIAGEN”), published a Recommended Public Conditional Voluntary Offer on 19 April 2016 (the “Offer”) to the shareholders of Exiqon A/S, Company reg. no. (CVR) 18984431 (“Exiqon”). QIAGEN extended the Offer Period, according to the Offer, on 19 May 2016 and on 3 June 2016. QIAGEN has decided […]
Acton, MA – Excellims Corporation (Excellims), a leading provider of high performance ion mobility spectrometers (HPIMS), announced that the Company has entered into an exclusive worldwide license agreement with Washington State University for a new instrumental method to interface an Ambient Pressure Ion Mobility Spectrometer (APIMS) to a Mass Spectrometer (MS). This new agreement is […]
FREMONT, Calif. and KUSASTSU, Japan, – WaferGen Bio-systems, Inc. (NASDAQ: WGBS), a publicly held genomics technology company (“WaferGen”), announced that it has entered into an exclusive distribution agreement in Japan with Takara Bio Inc. (“Takara”, TSE: 4974), a leading Japanese and global biotechnology and life science reagents company. The agreement is for promotion and technical […]
Thermo Fisher Scientific Inc., the world leader in serving science, and 908 Devices, a pioneer of purpose-built analytical devices for chemical analysis, will demonstrate the combination of 908 Devices’ new ZipChip microfluidics separation technology with Thermo Fisher’s mass spectrometers, delivering high-quality separations that transform MS analysis of biomolecules. These powerful technologies will be showcased, for […]
CARLSBAD, Calif. – Thermo Fisher Scientific launched the Ion Torrent Developers Alliance Program to support the development and commercialization of molecular in vitro diagnostics and clinical research assays using targeted next-generation sequencing (NGS) technology. Participants of the global Ion Torrent Developers Alliance Program are provided with flexible options to access Ion Torrent sequencing systems. With […]
SEELZE, Germany — Honeywell (NYSE: HON) announced it has expanded its distributor network for its portfolio of inorganics, solvents and other essential research chemicals for academic, pharmaceutical and industrial laboratories. Canadian Life Science, Canada’s leading supplier of chromatography, dissolution and spectroscopy essentials, has become an authorized distributor for Honeywell’s analytical chemistry portfolio in Canada. That […]
Atlanta, GA – Peak Serum, Inc. is proud to have announced its recent membership to Georgia Bio (GaBio), joining esteemed members such as The University of Georgia, Johnson & Johnson, Emory University and Sutherland. Georgia Bio is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. In an effort […]
Pay Invoice
Latest Blogs
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
